Author: Sachin ChaturvediPublisher:
ISBN: 9788171220878
Category : Biotechnology
Languages : en
Pages : 41
Book Description
Status of Biotechnology in Singapore
Author: Sachin ChaturvediPublisher:
ISBN: 9788171220878
Category : Biotechnology
Languages : en
Pages : 41
Book Description
Biotechnology in Singapore
Author: Tin Wee TanPublisher:
ISBN: 9789971622558
Category : Biotechnology
Languages : en
Pages : 50
Book Description
Singapore Biotech Guide
Author: Publisher:
ISBN:
Category : Biochemical engineering
Languages : en
Pages : 242
Book Description
Biotechnology in South Korea, Taiwan and Singapore
Author: Robert YuanPublisher: Springer
ISBN: 1349107662
Category : Science
Languages : en
Pages : 170
Book Description
This study examines biotechnology in the newly industrializing countries of Singapore, South Korea and Taiwan. Until recently, these countries have been known mainly for their first tentative moves into high technology. Government policy, research organizations and companies are covered.
Singapore Biotechnology, a Growing Industry
Author: Biotechnology in Singapore
Author: Publisher:
ISBN:
Category : Biotechnology industries
Languages : en
Pages : 27
Book Description
Biotechnology in Singapore, South Korea and Taiwan
Author: Robert T. YuanPublisher: Groves Dictionaries Incorporated
ISBN: 9780935859553
Category : Biotechnology
Languages : en
Pages : 168
Book Description
Biotechnology and Development
Author: Sachin ChaturvediPublisher: Academic Foundation
ISBN: 9788171883462
Category : Political Science
Languages : en
Pages : 334
Book Description
Biotechnology Is At The Heart Of Technology Revolution In Asia Today With Immense Potential In The Pharmaceutical And Agriculture Sectors. This Study Covers Economic And Policy Issues And The Experiences In Biotechnology In Japan, India, Malaysia, The Phillipines, Korea, Bangladesh, Thailand, China And Singapore And Also The International Cooperative Strategies Of Asean And In Europe. This Book Is A Valuable Resource For Governments, Multilateral Institutions, Academics And Practitioners In The Field Of Economic Development And Technology Policy Management.
Starting Up an Industry
Author: Emma ArmitagePublisher:
ISBN:
Category : Biotechnology industries
Languages : en
Pages : 188
Book Description
In 2000, Singapore's government launched a strategy to establish the biotechnology industry as one of the pillars of its future economic growth. This targeted 'causative' process involved support policies, the creation and strengthening of research bodies, construction of a purpose-built bio-hub, attraction of foreign drug companies, and investment in local start-ups. These organisations, support factors, and the networks between them constitute Singapore's national innovation system as it relates to biotech. Fourteen years on, Singapore's causative approach has resulted in job creation and increased per capita income. It has also seen many of biotechnology's top multinational corporations base a section of their operations within the country. However, the country's innovation system has yet to produce a community of Singapore-started small and medium sized dedicated biotechnology firms, referred to here as SDBFs. Small and medium sized firms are key drivers of innovation in the biotechnology sector and their presence is necessary to create a sustainable cluster. There is considerable interest from academia and industry in understanding and learning from the development of Singapore's local firms under its national innovation system. Hence, the purpose of this thesis is to study how Singapore's national innovation system has affected its biotechnology sector, with particular focus on its effect on SDBFs. This thesis used mixed methods to investigate the research question. The quantitative approach involved the construction of a database of Singapore-started biotechnology firms and their characteristics. The qualitative method utilised semi-structured interviews with 16 professionals in Singapore's biotechnology sector. The findings pointed to several key conclusions. Firstly, participants felt that increases in the availability of commercialisable patents, risk-comfortable venture capitalists, and entrepreneurial individuals are necessary factors to promote the emergence and success of start-up firms. Findings also showed that the majority of SDBFs studied are located outside of purpose-built hubs, which participants suggested might influence their business model. In addition, SDBFs appeared to be moving into the relatively 'lower risk' sub-sector of medical devices. Overall, a critical mass of firms, human capital, and support factors emerged as a state that Singapore must reach for the industry to thrive. This research builds on the body of work concerning the national innovation system framework and Singapore's biotechnology industry. It acts as a snapshot in time of SDBFs and the perspectives of a sample of individuals in the biotechnology industry. The data gathered here outlines the effect Singapore's national innovation system has had on the industry and emphasises the importance of the critical mass concept. This can be used to inform future policies and as an indicator of the characteristics of the SDBF level of the industry.
Author: Joon Khoi Lam